Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Avanir Pharmaceuticals |
---|---|
Information provided by: | Avanir Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT00113620 |
The purpose of this study is to determine whether dextromethorphan (Neurodex) and quinidine are effective in the treatment of pain of diabetic neuropathy.
Condition | Intervention | Phase |
---|---|---|
Pain Diabetic Neuropathy |
Drug: Neurodex |
Phase III |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of Dextromethorphan and Quinidine at Two Dose Levels in the Treatment of the Pain of Diabetic Neuropathy |
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 04-AVR-109 |
Study First Received: | June 9, 2005 |
Last Updated: | December 26, 2007 |
ClinicalTrials.gov Identifier: | NCT00113620 History of Changes |
Health Authority: | United States: Food and Drug Administration |
distal symmetrical pain lower extremities dextromethorphan |
Anti-Infective Agents Neurotransmitter Agents Adrenergic Agents Cholinergic Antagonists Pain Cholinergic Agents Naphazoline Antimalarials Neuromuscular Diseases Phenylpropanolamine Anti-Arrhythmia Agents Diabetes Complications Excitatory Amino Acids |
Diabetic Neuropathies Diabetes Mellitus Endocrine System Diseases Cardiovascular Agents Adrenergic alpha-Antagonists Muscarinic Antagonists Guaifenesin Quinidine Peripheral Nervous System Diseases Dextromethorphan Adrenergic Antagonists Endocrinopathy |
Anti-Infective Agents Respiratory System Agents Antiprotozoal Agents Neurotransmitter Agents Cholinergic Antagonists Molecular Mechanisms of Pharmacological Action Adrenergic Agents Physiological Effects of Drugs Excitatory Amino Acid Agents Cholinergic Agents Antimalarials Antiparasitic Agents Neuromuscular Diseases Therapeutic Uses Anti-Arrhythmia Agents |
Diabetes Complications Excitatory Amino Acid Antagonists Diabetic Neuropathies Nervous System Diseases Diabetes Mellitus Endocrine System Diseases Enzyme Inhibitors Cardiovascular Agents Adrenergic alpha-Antagonists Pharmacologic Actions Muscarinic Antagonists Quinidine Peripheral Nervous System Diseases Dextromethorphan Adrenergic Antagonists |